CARL ZEISS MEDITEC AG - BR (AFX.DE) Forecast, Price Target & Analyst Ratings
FRA:AFX • DE0005313704
25.04 EUR
-0.34 (-1.34%)
Last: Mar 6, 2026, 07:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CARL ZEISS MEDITEC AG - BR (AFX.DE).
Forecast Snapshot
Consensus Price Target
€37.68
+ 50.48% Upside
Next Earnings Forecast
Release DateMay 11, 2026
PeriodQ2 / 2026
EPS Estimate€0.44
Revenue Estimate545.86M
ChartMill Buy Consensus
66.09%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
€37.68
Upside
+ 50.48%
From current price of €25.04 to mean target of €37.68, Based on 23 analyst forecasts
Low
€28.79
Median
€32.64
High
€55.65
Price Target Revisions
1 Month
-24.30%
3 Months
-32.18%
Price Target Summary
23 analysts have analysed AFX.DE and the average price target is 37.68 EUR. This implies a price increase of 50.48% is expected in the next year compared to the current price of 25.04.
The average price target has been revised downward by 32.18% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
66.09%
AFX.DE was analyzed by 23 analysts. The buy percentage consensus is at 66. So analysts seem to be have mildly positive about AFX.DE.
In the previous month the buy percentage consensus was at a similar level.
AFX.DE was analyzed by 23 analysts, which is quite many. So the average rating should be quite meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-01-26 | Berenberg | Maintains | Hold -> Hold |
| 2025-12-12 | MWB RESEARCH AG | Maintains | Buy -> Buy |
| 2023-12-20 | EQUI.TS | Downgrade | Buy -> Neutral |
| 2022-12-15 | UBS | Maintains | |
| 2022-11-28 | UBS | Initiate | |
| 2022-10-31 | Deutsche Bank Capital | Initiate | |
| 2022-09-13 | Hauck Aufhäuser Investment Banking | Initiate | |
| 2022-09-13 | Berenberg Capital Markets | Initiate | |
| 2022-07-14 | Hauck Aufhäuser In... | Initiate | |
| 2022-04-21 | Hauck and Aufhaeuser | Initiate | |
| 2022-04-19 | Deutsche Bank Capital | Initiate | |
| 2022-03-16 | UBS | Initiate | |
| 2022-02-14 | HSBC | Initiate | |
| 2022-01-25 | Hauck Aufhäuser La... | Initiate | |
| 2021-12-10 | Kepler Cheuvreux | Initiate | |
| 2021-12-10 | Berenberg Bank | Initiate | |
| 2021-11-01 | Deutsche Bank | Initiate | |
| 2021-08-11 | Nord/LB | Initiate | |
| 2021-07-20 | Hauck & Aufhaeuser | Initiate | |
| 2021-07-20 | Berenberg Bank | Initiate | |
| 2021-07-10 | Hauck & Aufhaeuser | Initiate | |
| 2021-07-09 | Hauck & Aufhaeuser | Initiate | |
| 2021-06-21 | Deutsche Bank | Initiate | Buy |
| 2021-05-26 | Nord/LB | Initiate | Buy |
| 2021-05-26 | Berenberg Bank | Initiate | Neutral |
Next Earnings Forecast Details
Next Earnings Details
Release DateMay 11, 2026
PeriodQ2 / 2026
EPS Estimate€0.44
Revenue Estimate545.86M
Revenue Q2Q-2.53%
EPS Q2Q-14.44%
Number of Analysts5
Next Earnings Revisions
Revenue (1 Month)
-0.03%
Revenue (3 Months)
N/A
EPS (1 Month)
-17.33%
EPS (3 Months)
N/A
Next Earnings Summary
AFX.DE is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is 0.44 EUR and the consensus revenue estimate is 545.86M EUR.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.089B 9.80% | 2.066B -1.11% | 2.228B 7.82% | 2.269B 1.86% | 2.39B 5.33% | 2.522B 5.52% | 2.683B 6.38% | 2.857B 6.49% | |
| EBITDA YoY % growth | 422.187M -9.53% | 327.223M -22.49% | 349.698M 6.87% | 358.32M 2.47% | 404.99M 13.02% | 442.47M 9.25% | 452.57M 2.28% | 502.63M 11.06% | |
| EBIT YoY % growth | 348.124M -12.28% | 194.452M -44.14% | 223.32M 14.85% | 218.35M -2.23% | 273.59M 25.30% | 305.86M 11.80% | 359.45M 17.52% | 416.25M 15.80% | |
| Operating Margin | 16.66% | 9.41% | 10.02% | 9.62% | 11.45% | 12.13% | 13.40% | 14.57% | |
| EPS YoY % growth | N/A -7.77% | 2.01 -33.76% | 1.61 -19.90% | 1.63 1.24% | 2.05 26.02% | 2.39 16.13% | 2.74 15.00% | 3.23 17.73% |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|
| EPS Q2Q % growth | 0.44 -14.44% | 0.54 69.33% | 0.45 -22.97% |
| Revenue Q2Q % growth | 545.86M -2.53% | 573.22M 4.29% | 661.05M 5.34% |
| EBITDA Q2Q % growth | 72.324M -44.63% | 93.202M -4.11% | 106.53M -45.81% |
| EBIT Q2Q % growth | 46.633M -34.49% | 66.602M 23.43% | 73.251M 4.32% |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
21.31%
EPS Next 5 Year
16.66%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
4.40%
Revenue Next 5 Year
4.97%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
23.17%
EBIT Next 5 Year
16.12%
CARL ZEISS MEDITEC AG - BR / AFX.DE Forecast FAQ
What is the price target for AFX stock?
23 analysts have analysed AFX.DE and the average price target is 37.68 EUR. This implies a price increase of 50.48% is expected in the next year compared to the current price of 25.04.
When does CARL ZEISS MEDITEC AG - BR (AFX.DE) report earnings?
CARL ZEISS MEDITEC AG - BR (AFX.DE) will report earnings on 2026-05-11.
Can you provide the consensus estimates for CARL ZEISS MEDITEC AG - BR next earnings?
The consensus EPS estimate for the next earnings of CARL ZEISS MEDITEC AG - BR (AFX.DE) is 0.44 EUR and the consensus revenue estimate is 545.86M EUR.
How many analysts have analysed CARL ZEISS MEDITEC AG - BR (AFX.DE)?
The number of analysts covering CARL ZEISS MEDITEC AG - BR (AFX.DE) is 23.